Editorial Podcasts

On this month’s episode, we have the pleasure of speaking with Adam Jacques, Chief Geneticist of ZED Therapeutics and Zacariah Hildenbrand, Research Professor in the Department of Chemistry and Biochemistry at the University of Texas at El Paso, and a Director of the Curtis Mathes Corporation. Their article “Hemp Regulations and the Restrictions on Innovation” was the most popular piece on the Cannabis Science and Technology website in 2021. Our conversation is focused on the hemp research—plant genetics, research restrictions, testing—and more that Adam and Zac have been doing.

On this month’s episode, we have the pleasure of speaking with Michelle Finzel, President of Maryland Marketing Source, Inc., as well as the founders of Eighth Revolution: Bryan Fields, Managing Director and Kellan Finney, CSO. Our conversation is broken up into two-parts, but the overall theme is the data and trends we saw in 2021 and how that plays into the cannabis market for 2022.

Dr. John Abrams, Chairman and CSO of the Clinical Endocannabinoid System Consortium (CESC), shares some fascinating information about his background in the cannabis industry, current research projects, a terrific discussion on the cross-section of cannabinoids and virology, and more.